Peter Würl

3.4k total citations
106 papers, 2.7k citations indexed

About

Peter Würl is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Peter Würl has authored 106 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 51 papers in Oncology and 40 papers in Molecular Biology. Recurrent topics in Peter Würl's work include Sarcoma Diagnosis and Treatment (46 papers), Cancer-related Molecular Pathways (30 papers) and Cancer Research and Treatments (11 papers). Peter Würl is often cited by papers focused on Sarcoma Diagnosis and Treatment (46 papers), Cancer-related Molecular Pathways (30 papers) and Cancer Research and Treatments (11 papers). Peter Würl collaborates with scholars based in Germany, United States and United Kingdom. Peter Würl's co-authors include Helge Täubert, Thomas Greither, Matthias Bache, Axel Meye, Andrej Udelnow, Lukasz F. Grochola, Frank Bartel, Christine Lautenschläger, Matthias Kappler and Hannelore Schmidt and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Peter Würl

104 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Würl Germany 29 1.6k 949 833 641 261 106 2.7k
Hiroyuki Hamakawa Japan 32 1.3k 0.8× 1.4k 1.4× 542 0.7× 439 0.7× 476 1.8× 145 3.0k
Jim Heighway United Kingdom 32 2.3k 1.4× 1.6k 1.7× 720 0.9× 655 1.0× 244 0.9× 72 3.4k
Otto Sánchez Canada 22 1.3k 0.8× 909 1.0× 661 0.8× 363 0.6× 199 0.8× 41 2.5k
Sara Piccinin Italy 22 2.3k 1.4× 1.4k 1.5× 628 0.8× 584 0.9× 110 0.4× 29 3.4k
Hyeong-Reh Choi Kim United States 27 1.9k 1.2× 918 1.0× 913 1.1× 304 0.5× 165 0.6× 29 3.0k
Kathleen Cieply United States 30 940 0.6× 857 0.9× 400 0.5× 737 1.1× 695 2.7× 58 2.6k
Fumie Hosoda Japan 32 2.0k 1.2× 1.1k 1.2× 746 0.9× 696 1.1× 1.3k 4.9× 53 3.6k
Michele R. Wing United States 19 1.3k 0.8× 821 0.9× 649 0.8× 639 1.0× 406 1.6× 34 2.5k
Cristina E. Tognon United States 26 2.0k 1.2× 980 1.0× 705 0.8× 509 0.8× 307 1.2× 81 3.6k
V.V.V.S. Murty United States 26 2.5k 1.6× 606 0.6× 435 0.5× 375 0.6× 677 2.6× 42 3.8k

Countries citing papers authored by Peter Würl

Since Specialization
Citations

This map shows the geographic impact of Peter Würl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Würl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Würl more than expected).

Fields of papers citing papers by Peter Würl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Würl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Würl. The network helps show where Peter Würl may publish in the future.

Co-authorship network of co-authors of Peter Würl

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Würl. A scholar is included among the top collaborators of Peter Würl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Würl. Peter Würl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stracquadanio, Giovanni, Bart Vrugt, Renata Flury, et al.. (2016). CD44 SNPrs187115: A Novel Biomarker Signature that Predicts Survival in Resectable Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 22(24). 6069–6077. 7 indexed citations
2.
Keßler, Jacqueline, Swetlana Rot, Matthias Bache, et al.. (2016). miR-199a-5p regulates HIF-1α and OSGIN2 and its expression is correlated to soft-tissue sarcoma patients' outcome. Oncology Letters. 12(6). 5281–5288. 16 indexed citations
3.
4.
Yee, Karen S., Lukasz F. Grochola, Garth Hamilton, et al.. (2012). A RASSF1A Polymorphism Restricts p53/p73 Activation and Associates with Poor Survival and Accelerated Age of Onset of Soft Tissue Sarcoma. Cancer Research. 72(9). 2206–2217. 32 indexed citations
5.
Greither, Thomas, Franziska Koser, Matthias Kappler, et al.. (2012). Expression of human Piwi-likegenes is associated with prognosis for soft tissue sarcoma patients. BMC Cancer. 12(1). 272–272. 20 indexed citations
6.
Greither, Thomas, Peter Würl, Lukasz F. Grochola, et al.. (2011). Expression of microRNA 210 associates with poor survival and age of tumor onset of soft‐tissue sarcoma patients. International Journal of Cancer. 130(5). 1230–1235. 45 indexed citations
7.
Kotzsch, Matthias, Viktor Magdolen, Thomas Greither, et al.. (2011). Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patients. BMC Cancer. 11(1). 273–273. 11 indexed citations
8.
Vázquez, Alexei, Lukasz F. Grochola, Elisabeth E. Bond, et al.. (2009). Chemosensitivity Profiles Identify Polymorphisms in the p53 Network Genes 14-3-3τ and CD44 That Affect Sarcoma Incidence and Survival. Cancer Research. 70(1). 172–180. 43 indexed citations
9.
Grochola, Lukasz F., Alexei Vázquez, Elisabeth E. Bond, et al.. (2009). Recent Natural Selection Identifies a Genetic Variant in a Regulatory Subunit of Protein Phosphatase 2A that Associates with Altered Cancer Risk and Survival. Clinical Cancer Research. 15(19). 6301–6308. 20 indexed citations
10.
Udelnow, Andrej, Markus Huber‐Lang, Markus Juchems, et al.. (2009). How to Treat Esophageal Perforations When Determinants and Predictors of Mortality Are Considered. World Journal of Surgery. 33(4). 787–796. 12 indexed citations
11.
Grochola, Lukasz F., Thomas Müller, Gareth L. Bond, et al.. (2009). MDM2 SNP309 Associates With Accelerated Pancreatic Adenocarcinoma Formation. Pancreas. 39(1). 76–80. 15 indexed citations
12.
Greither, Thomas, Helge Täubert, Peter Möller, et al.. (2008). Prognostic Relevance of hTERT mRNA Expression in Ductal Adenocarcinoma of the Pancreas. Neoplasia. 10(9). 973–IN8. 19 indexed citations
13.
Täubert, Helge, Frank Bartel, Matthias Kappler, et al.. (2003). Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patients. Cancer. 97(9). 2273–2278. 16 indexed citations
14.
Würl, Peter, et al.. (2000). Detection of Cytokeratin-Positive Cells in Bone Marrow in Breast Cancer and Colorectal Carcinoma in Comparison with Other Factors of Prognosis. Journal of Hematotherapy & Stem Cell Research. 9(6). 905–911. 23 indexed citations
15.
Täubert, Helge, Matthias Kappler, Axel Meye, et al.. (2000). A MboII polymorphism in exon 11 of the human MDM2 gene occuring in normal blood donors and in soft tissue sarcoma patients: an indication for an increased cancer susceptibility?. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 456(1-2). 39–44. 4 indexed citations
16.
Meye, Axel, Peter Würl, Raoul Hinze, et al.. (1998). No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas. The Journal of Pathology. 184(1). 14–17. 13 indexed citations
17.
Würl, Peter, Axel Meye, Dieter Berger, et al.. (1998). Significance of retinoblastoma and mdm2 gene expression as prognostic markers for soft-tissue sarcoma. Langenbeck s Archives of Surgery. 383(1). 99–103. 17 indexed citations
18.
Täubert, Helge, Dieter Berger, Raoul Hinze, et al.. (1998). How is the mutational status for tumor suppressors p53 and p16INK4A in MFH of the bone?. Cancer Letters. 123(2). 147–151. 6 indexed citations
19.
Täubert, Helge, Axel Meye, Matthias Bache, et al.. (1998). p53 status in radiation-induced soft-tissue sarcomas. Strahlentherapie und Onkologie. 174(8). 427–430. 4 indexed citations
20.
Würl, Peter, Helge Täubert, Matthias Bache, et al.. (1996). Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors. International Journal of Cancer. 69(4). 317–323. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroyuki Hamakawa Breakdown of academic impact, for papers by Jim Heighway Breakdown of academic impact, for papers by Otto Sánchez Breakdown of academic impact, for papers by Sara Piccinin Breakdown of academic impact, for papers by Hyeong-Reh Choi Kim Breakdown of academic impact, for papers by Kathleen Cieply Breakdown of academic impact, for papers by Fumie Hosoda Breakdown of academic impact, for papers by Michele R. Wing Breakdown of academic impact, for papers by Cristina E. Tognon Breakdown of academic impact, for papers by V.V.V.S. Murty
Rankless by CCL
2026